Comment: HL comes highly recommended for M&A and held its position in major deals. Brandi’s work for notable banks for the first time (related to the Concardis sale) made the market sit up and take notice. HL successfully brought its global reach into play in advice to internationally active Mittelstand companies. The clear sector assignment pays dividends, be it Louven on the side of insurers, Hirschmann’s Hamburg energy team, which was involved in every central offshore wind farm deal, or Angerer in pharma transactions. Besides these established partners, the younger partners are raising their profiles. Zirngibl is growing beyond his role as a corporate VC specialist and has now steered major M&A deals, e.g. for Daimler.
Strengths: Strong focus on the ?insurance, ?pharmaceuticals and healthcare, ?energy and chemicals sectors. The European corporate group is closely integrated.
Development potential: HL is now one of the firms advising on high-volume deals, but is still not visible in public takeovers. External reinforcements will be unavoidable if the firm hopes to catch up to the leading practices.
Recommended: Dr. Andreas Meyer, Dr. Christoph Louven (“spot-on advice, his deal handling sets him apart”, client), Dr. Volker Geyrhalter, Dr. Tim Brandi, Matthias Hirschmann, Dr. Nikolas Zirngibl, Jens Uhlendorf, Dr. Matthias Jaletzke.
Practice: Hamburg: focus on Scandinavian investments, energy, steel and media; Düsseldorf: insurance and chemicals; Munich: high tech and pharma; Frankfurt: financial institutions. (Corporate in total: 20 equity partners, 6 salary partners, 3 counsel, 15 associates)
Clients: ?? Consortium of Deutsche Bank, UniCredit, DZ Bank on sale of Concardis; FlixMobility on takeover of parts of European business of Megabus Europe; Perkin Elmer on sale of Medical Imaging; Northland Power on acquisition of offshore wind farm project Deutsche Bucht; Statoil on takeover of 50 percent share in AWE-Arkona-Windparkgesellschaft.
  • Teilen